Carna Biosciences, Inc.

TSE:4572.T

304 (JPY) • At close November 5, 2024
Bedrijfsnaam Carna Biosciences, Inc.
Symbool 4572.T
Munteenheid JPY
Prijs 304
Beurswaarde 5,805,906,304
Dividendpercentage 0%
52-weken bereik 285 - 876
Industrie Biotechnology
Sector Healthcare
CEO Dr. Kohichiro Yoshino Ph.D.
Website https://www.carnabio.com

An error occurred while fetching data.

Over Carna Biosciences, Inc.

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers

Vergelijkbare Aandelen

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,379 JPY

JTEC Corporation logo

JTEC Corporation

3446.T

1,660 JPY

Solasia Pharma K.K. logo

Solasia Pharma K.K.

4597.T

47 JPY

SEED Co.,Ltd. logo

SEED Co.,Ltd.

7743.T

493 JPY

OLBA HEALTHCARE HOLDINGS, Inc. logo

OLBA HEALTHCARE HOLDINGS, Inc.

2689.T

1,984 JPY

DVx Inc. logo

DVx Inc.

3079.T

902 JPY

MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370.T

42 JPY

Precision System Science Co., Ltd. logo

Precision System Science Co., Ltd.

7707.T

279 JPY

OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc.

4564.T

32 JPY

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,777 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)